Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Sun, 11/20/16 - 05:33 pm
Tags:
Medicare, H.P. Acthar Gel, Mallinckrodt, Remodulin, United Therapeutics, Tyvaso, Provenge, Valeant Pharmaceuticals, Gilead Sciences, Harvoni
Gilead Fails to Beat Incyte’s Jakafi Drug
Investopedia
Sat, 11/19/16 - 11:32 am
Tags:
Gilead Sciences, Jakafi, Incyte, momelotinib, myelofibrosis
Should Gilead Sciences Purchase Incyte?
Seeking Alpha
Fri, 11/18/16 - 10:02 am
Tags:
Gilead Sciences, Incyte, M&A
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Tags:
Gilead Sciences, Biogen, JNJ, drug launches, AbbVie, Sovaldi, Imbruvica, Tecfidera
After The Deluge, Hep C Players Look For Opportunity
Seeking Alpha
Thu, 11/17/16 - 09:57 am
Tags:
hepatitis C, Gilead Sciences, AbbVie, Epclusa, glecaprevir/pibrentasvir, sofosbuvir/velpatasvir
3 Potential Acquisition Targets for Gilead Sciences, Inc.
Motley Fool
Wed, 11/16/16 - 10:00 pm
Tags:
Gilead Sciences, Kite Pharma, Tesaro, Intercept Pharma, M&A
AbbVie's pan-genotypic hep C prospect shines in trials, putting the heat on rival Gilead
Fierce Pharma
Tue, 11/15/16 - 09:36 am
Tags:
AbbVie, hepatitis C, Gilead Sciences, Epclusa
Gilead hepatitis C pill was biggest 2015 drug cost for Medicare, Medicaid
Stat/Pharmalot
Tue, 11/15/16 - 09:24 am
Tags:
Gilead Sciences, hepatitis C, Medicare, Medicaid, Harvoni
3 Drugmakers That Probably Have Lower Tax Rates Than You Do
Motley Fool
Sun, 11/13/16 - 11:57 am
Tags:
taxes, Amgen, Gilead Sciences, Eli Lilly
Gilead's hepatitis B drug gets U.S. approval
BioPharma Dive
Thu, 11/10/16 - 04:12 pm
Tags:
Gilead Sciences, Vemlidy, hepatitis B
Gilead Sciences: 5 Reasons to Buy Alexion…and 4 Reasons It Shouldn’t
Barron's
Tue, 11/8/16 - 04:44 pm
Tags:
Gilead Sciences, Alexion, M&A
Gilead Sciences: No M&A, No Pipeline?
Barron's
Mon, 11/7/16 - 09:13 pm
Tags:
Gilead Sciences, M&A
3 Best Biotech Stocks of the 21st Century (So Far)
Motley Fool
Sun, 11/6/16 - 12:22 pm
Tags:
biotech, Acorda Therapeutics, Gilead Sciences, Celgene
5 Things Gilead Sciences' Management Said After Its Earnings Plummet
Motley Fool
Thu, 11/3/16 - 09:40 am
Tags:
Gilead Sciences, earnings
Gilead's Q3 Bombshell: No More Hepatitis C R&D
Motley Fool
Thu, 11/3/16 - 09:33 am
Tags:
Gilead Sciences, R&D, hepatitis C
Gilead Sciences: Is an Acquisition the Right Prescription?
Barron's
Wed, 11/2/16 - 10:22 pm
Tags:
Gilead Sciences, M&A
Gilead Sciences shares slide after revenue beat, earnings miss
Marketwatch
Tue, 11/1/16 - 04:58 pm
Tags:
Gilead Sciences, earnings
Gilead Sciences Part 1: Before The Earnings News
Seeking Alpha
Mon, 10/31/16 - 06:34 pm
Tags:
Gilead Sciences, earnings
Unfazed by FDA Warning, Gilead Sciences' Stock Could Be Turning a Corner
Motley Fool
Sat, 10/29/16 - 01:19 pm
Tags:
FDA, Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Lilly, GSK, Gilead outsourced the most in Q3: report
BioPharma Dive
Thu, 10/27/16 - 10:22 pm
Tags:
Eli Lilly, Gilead Sciences, GSK, R&D, outsourcing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.